Geneplus Global LTD

Cover Block

Item	Details
Company Name	Geneplus Global LTD
Tagline	Provides livestock genetics, nutrition, health solutions and tech-driven breeding services for East African smallholder farmers.
Headquarters	Nairobi, Kenya
Stage	Seed
Business Model	B2C
Industry	Agtech
Technology Type	Biotech / Life Sciences
Geography	Sub-Saharan Africa
Growth Profile	Social Enterprise / Nonprofit Hybrid
Founding Team	Dr. Chris Silali
Funding Label	Undisclosed

Links

• Website. https://geneplusglobal.com/ [Geneplus Global, Unknown]
• LinkedIn. https://ke.linkedin.com/company/geneplusglobal [LinkedIn, Unknown]
• Facebook. https://www.facebook.com/geneplusglobal/ [Facebook, Unknown]

Summary and Signal

Geneplus Global is a Nairobi-based agtech company attempting to modernize livestock farming for East Africa's smallholder dairy producers. It bundles genetics, health, and nutrition with a tech-enabled last-mile service [Geneplus Global, Unknown]. The company's thesis is that fragmented access to quality inputs is a primary constraint on farm productivity.

Its core offering, Geneplus Easy Breed®, combines high-quality semen and breeding stock with delivery and advisory services. This model seeks to differentiate through bundled convenience and local market knowledge rather than novel biotech [BioSpace, 2024]. The company is led by Dr. Chris Silali.

Geneplus participated in the SAIS Accelerator program in 2024 [SAIS Accelerator, Unknown]. Its capital structure is anchored by a seed investment from Sahel Capital in 2024, though the amount is undisclosed. It operates a B2C sales model targeting individual farmers [Sahel Capital, 2024].

Over the next 12-18 months, key indicators to monitor include the scale of its last-mile service deployment. Watch for publication of any customer traction or yield improvement data. Also track expansion of its partnership with genetics provider ABS Global beyond the currently cited collaboration [Geneplus Global, Unknown].

Data Accuracy: YELLOW -- Core company description and investor relationship are confirmed, but key operational and financial details are sourced primarily from the company.

Taxonomy Snapshot

Axis	Classification
Stage	Seed
Business Model	B2C
Industry / Vertical	Agtech
Technology Type	Biotech / Life Sciences
Geography	Sub-Saharan Africa
Growth Profile	Social Enterprise / Nonprofit Hybrid

Company Overview

Geneplus Global LTD is a Nairobi-based agtech company that provides livestock genetics, nutrition, and health solutions to smallholder farmers in East Africa [Geneplus Global, Unknown].

Key milestones include participation in the SAIS Accelerator program in 2024. This is a startup initiative focused on scaling digital agriculture innovations in East Africa [SAIS Accelerator, Unknown]. In the same year, the firm secured an undisclosed investment from Sahel Capital. Sahel Capital is a private investment firm focused on food and agriculture in sub-Saharan Africa. It described the deal as providing "quality livestock genetic products to dairy farmers in Kenya" [Sahel Capital, 2024].

Data Accuracy: YELLOW -- Company description and accelerator participation are confirmed. Founding date and investment amount are not publicly available.

The Product and the Stack

Geneplus Global's offering is a bundled service for smallholder livestock farmers. It combines physical inputs with a technology-enabled delivery model. The company provides high-quality genetically superior breeding stock, advanced breeding techniques, and a last-mile service branded as Geneplus Easy Breed® [Geneplus Global].

Its product suite extends into animal nutrition and health solutions. These are supported by a claimed end-to-end cold chain delivery system [Geneplus Global]. A specific application is providing dairy farmers with sexed and unsexed cattle semen to enhance herd productivity and boost milk yields [BioSpace, 2024].

The technology component appears focused on logistics and service delivery rather than proprietary biotech. The company's website describes facilitating commercial solutions through partnerships. It notably mentions a collaboration with ABS Global, a global leader in bovine genetics, for its breeding program [Geneplus Global].

• Service integration. The value proposition hinges on integrating genetics, nutrition, and health products with a reliable delivery and advisory service.
• Partnership-driven tech. The advanced breeding techniques are delivered in partnership with ABS Global.
• Last-mile focus. The Geneplus Easy Breed® service is positioned as the key differentiator.

Data Accuracy: YELLOW -- Product claims are sourced from the company's website and a secondary industry article; the partnership with ABS Global is cited.

Market Research and Opportunity

The opportunity for livestock genetics in East Africa is defined by a persistent gap between the genetic potential of smallholder herds and the inputs and services available to unlock it. The company's primary target is Kenya's smallholder dairy segment. It estimates this comprises over 1.8 million farmers [Geneplus Global, Unknown].

The total addressable market for animal genetics is projected to reach a valuation of $12.11 billion by 2034 [BioSpace, 2024].

Data Accuracy: YELLOW -- Market sizing relies on a single company estimate and a global industry report used as an analogous reference.

The Competitive Field

Company	Positioning	Stage / Funding	Notable Differentiator
Geneplus Global LTD	Integrated provider of livestock genetics, nutrition, health, and last-mile breeding services for smallholders.	Seed (2024); investor Sahel Capital.	Bundled offering with proprietary Geneplus Easy Breed® last-mile service.
Sidai Africa Ltd	Integrated animal health service provider operating a network of franchised agro-vet outlets across Kenya.	Later stage; has raised multiple rounds from impact investors.	Extensive physical retail and service network, strong brand recognition among farmers.

Data Accuracy: YELLOW -- Limited public data on competitors; Geneplus Global's positioning is based on its own claims.

Opportunity

The opportunity for Geneplus Global is to become the primary provider of integrated genetics and health services for the millions of smallholder livestock farmers in East Africa. The backing by Sahel Capital provides a credible partner for scaling this integrated service model [Sahel Capital, 2024].

Data Accuracy: YELLOW -- Core opportunity thesis is built on company-stated goals and investor profile.

Sources

1. [Geneplus Global, Unknown] Geneplus Global LTD | Specialists in Agricultural Technology - Kenya | https://geneplusglobal.com/
2. [SAIS Accelerator, Unknown] Geneplus Global - SAIS Accelerator | https://sais-accelerator.com/start-up-profile/geneplus-global/
3. [LinkedIn, Unknown] Geneplus Global Limited | LinkedIn | https://ke.linkedin.com/company/geneplusglobal
4. [Facebook, Unknown] Geneplus Global | Nairobi | Facebook | https://www.facebook.com/geneplusglobal/
5. [BioSpace, 2024] Animal Genetics Market Size on Track for USD 12.11 Billion Valuation by 2034 - BioSpace | https://www.biospace.com/press-releases/animal-genetics-market-size-on-track-for-usd-12-11-billion-valuation-by-2034
6. [Sahel Capital, 2024] Geneplus Global Ltd - Sahel Capital | https://sahelcapital.com/member/geneplus-global-ltd/
7. [Sahel Capital, Nov 2024] Investment Geneplus Global Limited | https://sahelcapital.com/wp-content/uploads/2024/11/Investment-in-Geneplus-Global-Limited.pdf
8. [Competitor data] Sidai Africa Ltd |